Ferulic Acid reduces amyloid beta mediated neuroinflammation through modulation of Nurr1 expression in microglial
Ali Moghimi-Khorasgani1,2, Farshad Homayouni Moghadam2, Mohammad Hossein Nasr-Esfahani2
1Department of Biology, Faculty of Science and Technology, ACECR Institute of Higher Education (Isfahan Branch), Isfahan, Iran.
Abstract:
Microglial cells (MGCs) serve as the resident macrophages in the brain and spinal cord, acting as the first line of immune defense against pathological changes. With various phenotypes, they can shift from a homeostatic state to a reactive state or transit from a reactive to a non-inflammatory reactive state (alternative homeostatic). A well-timed transit is crucial in limiting excessive microglial reaction and promoting the healing process. Studies indicate that increased Nurr1 expression promotes anti-neuroinflammatory responses in the brain. In this study, we investigated the possible role of ferulic acid (FA) in facilitating microglia transition due to its anti-inflammatory and Nurr1-inducing effects. MGCs were extracted from the brains of male NMRI mice at postnatal day 2 (P2) and cultured with or without FA and beta-amyloid (Aβ). Real-time qRT-PCR was conducted to measure the expressions of Nurr1, IL-1β, and IL-10 genes. Immunostaining was performed to determine the number of NURR1-positive cells, and the ramification index (RI) of MGCs was calculated using Image J software. Treating MGCs with FA (50 μg/ml) induced Nurr1 and IL-10 expressions, while reducing the level of IL-1β in the absence of Aβ-stress. Further assessments on cells under Aβ-stress showed that FA treatment restored the IL-10 and Nurr1 levels, increased the RI of cells, and the number of NURR1-positive cells. Morphological assessments and measurements of the RI revealed that FA treatment reversed amoeboid and rod-like cells to a ramified state, which is specific morphology for non-inflammatory reactive microglia. To conclude, FA can provide potential alternative homeostatic transition in Aβ-reactive microglia by recruiting the NURR1 dependent anti-inflammatory responses. This makes it a promising therapeutic candidate for suppressing Aβ-induced neuroinflammatory responses in MGCs. Furthermore, given that FA has the ability to increase NURR1 levels in homeostatic microglia, it could be utilized as a preventative medication.
Insights
Ferulic acid (FA) helps brain immune cells called microglia transition to a non-inflammatory state. FA promotes healing by increasing Nurr1 expression and reducing inflammation, offering a potential treatment for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglial cells (MGCs) are brain macrophages crucial for immune defense.
- MGCs can shift between homeostatic and reactive states, with timely transitions aiding healing.
- Nurr1 expression is linked to anti-neuroinflammatory effects in the brain.
Purpose of the Study:
- To investigate ferulic acid's (FA) role in facilitating microglial transition.
- To explore FA's potential to modulate microglial phenotypes via anti-inflammatory and Nurr1-inducing effects.
Main Methods:
- Primary microglial cells (MGCs) were isolated from mice.
- Cells were treated with ferulic acid (FA) and beta-amyloid (Aβ).
- Gene expression (Nurr1, IL-1β, IL-10) was analyzed via qRT-PCR; cell morphology and NURR1-positive cells were assessed via immunostaining and Image J software.
Main Results:
- FA treatment increased Nurr1 and IL-10, while decreasing IL-1β in MGCs.
- Under Aβ-stress, FA restored IL-10 and Nurr1 levels and increased the ramification index (RI).
- FA promoted a shift from reactive (amoeboid/rod-like) to non-inflammatory ramified MGC morphology.
Conclusions:
- Ferulic acid facilitates an alternative homeostatic transition in Aβ-reactive microglia.
- FA's NURR1-dependent anti-inflammatory actions suggest therapeutic potential for neuroinflammation.
- FA may serve as a preventative medication by increasing NURR1 in homeostatic microglia.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Treatment


